Reply

Terence McSwiney¹, Barry Power², Conor C Murphy^{1

3}, Donal Brosnahan^{1

4}, William Power^{1

3}

Affiliations

Comment

Terence McSwiney et al. Cornea. 2020 Feb.

. 2020 Feb;39(2):e5.

doi: 10.1097/ICO.0000000000002188.

Terence McSwiney¹, Barry Power², Conor C Murphy^{1

3}, Donal Brosnahan^{1

4}, William Power^{1

3}

No abstract available

Comment on

Safety and Efficacy of Supratarsal Triamcinolone for Treatment of Vernal Keratoconjunctivitis in Ireland.
McSwiney TJ, Power B, Murphy CC, Brosnahan D, Power W. McSwiney TJ, et al. Cornea. 2019 Aug;38(8):955-958. doi: 10.1097/ICO.0000000000001963. Cornea. 2019. PMID: 31276459
Comment on: "Safety and Efficacy of Supratarsal Triamcinolone for Treatment of Vernal Keratoconjunctivitis in Ireland".
Sahay P, Kumawat D. Sahay P, et al. Cornea. 2020 Feb;39(2):e5. doi: 10.1097/ICO.0000000000002187. Cornea. 2020. PMID: 31725700 No abstract available.

1. Chatterjee S, Agrawal D. Tacrolimus in corticosteroid-refractory vernal keratoconjunctivitis. Cornea. 2016;35:1444–1448.
1. De Smedt S, Wildner G, Kestelyn P. Vernal keratoconjunctivitis: an update. Br J Ophthalmol. 2013;97:9–14.